1. Bjoro, K., Bell, H., Helium, K., Myrvang, B., and Skaug, K., 2000, Randomized trial of IFNA induction and ribavirin vs standard IFN-A and ribavirin for chronic HCV in previously untreated patients. Hepatology 32(4): 317A-632.
2. Booth, J.C.L., Foster, G.R., Kumar, U., Galassini, R., Goldin, R.D., Brown, J.L., et al., 1995, Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon α. Gut 36: 427–432.
3. Brillanti, S., Levantesi, F., Masi, L., Foli, M., and Bolondi, L., 2000, Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C. Hepatology 32(3): 630–634.
4. Carithers, R.L., Zeuzem, S., Manns, M.P., et al., 2000, Multicenter, randomized, controlled trial comparing high dose daily induction interferon plus ribavirin versus standard interferon alfa-2b plus ribavirin. Hepatology 32(4): 317A-631.
5. Chemello, L., Cavaletto, L., Bemardello, E., Guido, M., Pontisso, P., and Alberti, A., 1995, The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. J. Hepatol. 23 8–12.